Hsbc Holdings PLC Sells 8,398 Shares of Cabot Corporation $CBT

Hsbc Holdings PLC trimmed its holdings in shares of Cabot Corporation (NYSE:CBT) by 72.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,117 shares of the specialty chemicals company’s stock after selling 8,398 shares during the period. Hsbc Holdings PLC’s holdings in Cabot were worth $235,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of CBT. Fuller & Thaler Asset Management Inc. grew its holdings in shares of Cabot by 5.6% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after purchasing an additional 124,613 shares during the last quarter. State Street Corp raised its holdings in shares of Cabot by 1.0% in the fourth quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock valued at $134,256,000 after buying an additional 20,021 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Cabot by 3.9% in the third quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock valued at $128,032,000 after buying an additional 63,080 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Cabot by 6.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,663,283 shares of the specialty chemicals company’s stock worth $110,243,000 after buying an additional 106,521 shares in the last quarter. Finally, Sei Investments Co. lifted its position in Cabot by 2.4% during the 3rd quarter. Sei Investments Co. now owns 1,008,847 shares of the specialty chemicals company’s stock worth $76,722,000 after buying an additional 23,267 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Trading Up 2.2%

Shares of NYSE CBT opened at $90.00 on Tuesday. Cabot Corporation has a fifty-two week low of $58.33 and a fifty-two week high of $94.53. The firm has a market capitalization of $4.65 billion, a P/E ratio of 17.01, a P/E/G ratio of 11.46 and a beta of 0.84. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.45 and a quick ratio of 0.96. The company’s 50 day simple moving average is $88.03 and its 200 day simple moving average is $79.56.

Cabot (NYSE:CBT) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. During the same quarter in the previous year, the business earned $1.90 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, analysts predict that Cabot Corporation will post 6.35 EPS for the current year.

Cabot Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be given a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is currently 35.73%.

Analyst Ratings Changes

CBT has been the subject of several research reports. JPMorgan Chase & Co. raised their price objective on shares of Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research report on Wednesday, May 13th. Truist Financial started coverage on shares of Cabot in a research report on Monday, June 8th. They set a “buy” rating and a $98.00 target price on the stock. UBS Group increased their price target on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Finally, Wall Street Zen cut shares of Cabot from a “buy” rating to a “hold” rating in a research report on Saturday. Two research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $85.80.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.